Skip to content

Public FDA record

Z-1043-2026: A71200 Vanta" Clinician Programmer Application (CP App) version 2.0.2465 and 2.0.2683, Product number A71

Recall record Z-1043-2026 for Medtronic Neuromodulation. View source facts, labeled dates, and the original FDA record.

FDA identifier
Z-1043-2026
Company in FDA record
Medtronic Neuromodulation
FDA classification date
Jan 9, 2026
First observed by MedTech Watch
Nov 16, 2026
Latest observed content change
Nov 16, 2026
Recall classification
Class II

Reason stated in the source

Complaints received that Vanta A71200 CP App does not function as intended during use. There is a potential for prolonged or postponed surgical procedure.

Source facts

Action
On December 3, 2025 the firm distributed Urgent Medical Device Safety Notification letters to affected consignees. Customers were instructed to download and install A81200 CP App v2.0.2684 or any later version.
Initiated
2025-12-03
Root cause
Software design
Distribution
Worldwide - US Nationwide distribution.
Recall number
Z-1043-2026
Recall status
Open, Classified
CDRH record ID
217610
FDA classified
2026-01-09
Recall event number
98097

Source facts and excerpts are reproduced for research. Dates retain their source meanings. “First observed” describes collection, not FDA publication or product launch.

Recall classification is supplied only when the recall number matches an enforcement record. Recall class and device class are different fields. Several recall records may belong to one recall event.

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 22, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗